Sathya N Thulasi Raman
Overview
Explore the profile of Sathya N Thulasi Raman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamming L, Duque D, Tran A, Lansdell C, Frahm G, Wu J, et al.
Mol Ther Methods Clin Dev
. 2025 Jan;
33(1):101388.
PMID: 39759470
[This corrects the article DOI: 10.1016/j.omtm.2024.101325.].
2.
Tamming L, Duque D, Bavananthasivam J, Tran A, Lansdell C, Frahm G, et al.
Mol Ther Methods Clin Dev
. 2024 Sep;
32(3):101325.
PMID: 39309757
The effectiveness of mRNA vaccines largely depends on their lipid nanoparticle (LNP) component. Herein, we investigate the effectiveness of DLin-KC2-DMA (KC2) and SM-102-based LNPs for the intramuscular delivery of a...
3.
Pfeifle A, Zhang W, Cao J, Thulasi Raman S, Anderson-Duvall R, Tamming L, et al.
Emerg Microbes Infect
. 2024 Sep;
13(1):2399949.
PMID: 39221484
The rising prevalence of Lyme disease (LD) in North America and Europe has emerged as a pressing public health concern. Despite the availability of veterinary LD vaccines, no vaccine is...
4.
Zhang W, Pfeifle A, Lansdell C, Frahm G, Cecillon J, Tamming L, et al.
Vaccines (Basel)
. 2023 Oct;
11(10).
PMID: 37896985
In recent years, lipid nanoparticles (LNPs) have emerged as a revolutionary technology for vaccine delivery. LNPs serve as an integral component of mRNA vaccines by protecting and transporting the mRNA...
5.
Pfeifle A, Thulasi Raman S, Lansdell C, Zhang W, Tamming L, Cecillon J, et al.
Front Immunol
. 2023 Apr;
14:1020134.
PMID: 37006299
Introduction: The incidence of Lyme disease (LD) in Canada and the United States has risen over the last decade, nearing 480,000 cases each year. sensu lato, the causative agent of...
6.
Thulasi Raman S, Zetner A, Hashem A, Patel D, Wu J, Gravel C, et al.
Emerg Microbes Infect
. 2023 Mar;
12(1):2192821.
PMID: 36927227
Influenza and Respiratory Syncytial virus (RSV) infections together contribute significantly to the burden of acute lower respiratory tract infections. Despite the disease burden, no approved RSV vaccine is available. While...
7.
Tamming L, Duque D, Tran A, Zhang W, Pfeifle A, Laryea E, et al.
Front Immunol
. 2022 Jan;
12:785349.
PMID: 35095861
SARS-CoV-2 infections present a tremendous threat to public health. Safe and efficacious vaccines are the most effective means in preventing the infections. A variety of vaccines have demonstrated excellent efficacy...
8.
Russell M, Thulasi Raman S, Gravel C, Zhang W, Pfeifle A, Chen W, et al.
Front Immunol
. 2021 Oct;
12:747866.
PMID: 34603336
Respiratory syncytial virus (RSV) is a leading cause of respiratory infections worldwide and disease management measures are hampered by the lack of a safe and effective vaccine against the infection....
9.
Thulasi Raman S, Latreille E, Gao J, Zhang W, Wu J, Russell M, et al.
Emerg Microbes Infect
. 2020 Sep;
9(1):2046-2060.
PMID: 32873194
Zika virus (ZIKV) infection is a serious public threat with cases reported in about 70 countries and territories. One of the most serious consequences of ZIKV infection is congenital microcephaly...
10.
Liu G, Lu Y, Thulasi Raman S, Xu F, Wu Q, Li Z, et al.
Nat Commun
. 2018 Aug;
9(1):3199.
PMID: 30097581
The nucleus represents a cellular compartment where the discrimination of self from non-self nucleic acids is vital. While emerging evidence establishes a nuclear non-self DNA sensing paradigm, the nuclear sensing...